Brain is the key target for many drugs used in obesity and aging. Currently marketed anti-obesity and anti-aging regimes are available in oral dosage forms having limited brain uptake due to the strict blood brain barrier. To overcome this barrier novel, practical and non-invasive intranasal route was attempted to deliver drugs in microemulsion or mucoadhesive microemulsion to the brain. Bromocriptine and cabergoline were selected as the test drugs as review of recent research reveal the possible application of these as anti-obesity and anti-aging therapeutics. The in-vivo pharmacokinetic studies in Swiss albino rats confirmed the intranasal route a rational approach to deliver these drugs selectively and effectively to the brain than intravenous or oral administrations. The in-vivo pharmacodynamic studies confirmed the efficacy of bromocriptine and cabergoline as anti-obesity and anti-ageing drugs. These preliminary but encouraging results are provoking to conduct long term studies in at least two more animal models followed by extensive clinical evaluation for a product for clinical use.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Brain is the key target for many drugs used in obesity and aging. Currently marketed anti-obesity and anti-aging regimes are available in oral dosage forms having limited brain uptake due to the strict blood brain barrier. To overcome this barrier novel, practical and non-invasive intranasal route was attempted to deliver drugs in microemulsion or mucoadhesive microemulsion to the brain. Bromocriptine and cabergoline were selected as the test drugs as review of recent research reveal the possible application of these as anti-obesity and anti-aging therapeutics. The in-vivo pharmacokinetic studies in Swiss albino rats confirmed the intranasal route a rational approach to deliver these drugs selectively and effectively to the brain than intravenous or oral administrations. The in-vivo pharmacodynamic studies confirmed the efficacy of bromocriptine and cabergoline as anti-obesity and anti-ageing drugs. These preliminary but encouraging results are provoking to conduct long term studies in at least two more animal models followed by extensive clinical evaluation for a product for clinical use. 128 pp. Englisch. N° de réf. du vendeur 9783845430027
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. N° de réf. du vendeur 5482100
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Brain is the key target for many drugs used in obesity and aging. Currently marketed anti-obesity and anti-aging regimes are available in oral dosage forms having limited brain uptake due to the strict blood brain barrier. To overcome this barrier novel, practical and non-invasive intranasal route was attempted to deliver drugs in microemulsion or mucoadhesive microemulsion to the brain. Bromocriptine and cabergoline were selected as the test drugs as review of recent research reveal the possible application of these as anti-obesity and anti-aging therapeutics. The in-vivo pharmacokinetic studies in Swiss albino rats confirmed the intranasal route a rational approach to deliver these drugs selectively and effectively to the brain than intravenous or oral administrations. The in-vivo pharmacodynamic studies confirmed the efficacy of bromocriptine and cabergoline as anti-obesity and anti-ageing drugs. These preliminary but encouraging results are provoking to conduct long term studies in at least two more animal models followed by extensive clinical evaluation for a product for clinical use. N° de réf. du vendeur 9783845430027
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Brain is the key target for many drugs used in obesity and aging. Currently marketed anti-obesity and anti-aging regimes are available in oral dosage forms having limited brain uptake due to the strict blood brain barrier. To overcome this barrier novel, practical and non-invasive intranasal route was attempted to deliver drugs in microemulsion or mucoadhesive microemulsion to the brain. Bromocriptine and cabergoline were selected as the test drugs as review of recent research reveal the possible application of these as anti-obesity and anti-aging therapeutics. The in-vivo pharmacokinetic studies in Swiss albino rats confirmed the intranasal route a rational approach to deliver these drugs selectively and effectively to the brain than intravenous or oral administrations. The in-vivo pharmacodynamic studies confirmed the efficacy of bromocriptine and cabergoline as anti-obesity and anti-ageing drugs. These preliminary but encouraging results are provoking to conduct long term studies in at least two more animal models followed by extensive clinical evaluation for a product for clinical use.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 128 pp. Englisch. N° de réf. du vendeur 9783845430027
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Aging and Weight Control by Nose to Brain Drug Delivery | Intranasal Delivery of Therapeutics for Aging and Weight Control | Ambikanandan Misra (u. a.) | Taschenbuch | 128 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783845430027 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 106843017
Quantité disponible : 5 disponible(s)